Clinical Trial Update: Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1/Phase 2 study evaluating local treatment of metastatic melanoma using autologous lymphocytes in combi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Autologous lymphocytes (Autologous lymphocytes)
• rM28 (rM28 bispecific antibody)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Malignant Melanoma | Phase 1, Phase 2 | Status: COMPLETED